PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Gastroenterology, Hepatology and Nutrition, Schneider Children\'s Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: nzevit@gmail.com.\', \'Mount Sinai Center for Eosinophilic Disorders, Icahn School of Medicine at Mount Sinai, New York, NY.\', \'Boston Specialists LLC, Boston, Mass; Department of Gastroenterology, Tufts Medical Center, Boston, Mass.\', \'Division of Gastroenterology, The Ottawa Hospital IBD Centre, Ottawa, Ontario, Canada.\', \'Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC; Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2213-2198(21)01138-710.1016/j.jaip.2021.10.019
?:hasPublicationType
?:journal
  • The journal of allergy and clinical immunology. In practice
is ?:pmid of
?:pmid
?:pmid
  • 34688963
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Eosinophilic Esophagitis Patients Are Not at Increased Risk of Severe COVID-19: A Report From a Global Registry.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all